scanX
Home
Ortin Global

Ortin Global

21.38
+0.34
(1.62%)
Market Cap (₹ Cr.)
₹17
52 Week High
23.90
Book Value
₹
52 Week Low
19.55
PE Ratio
PB Ratio
6.12
PE for Sector
38.62
PB for Sector
4.68
ROE
-0.86 %
ROCE
-2,062.95 %
Dividend Yield
0.00 %
EPS
₹0.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-62.31 %
Net Income Growth
-8,490.81 %
Cash Flow Change
-1,816.00 %
ROE
-32,952.98 %
ROCE
-1,05,885.73 %
EBITDA Margin (Avg.)
-3,100.56 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
23
12
13
14
25
12
15
14
24
12
10
17
42
33
44
44
47
41
30
54
72
79
77
52
2
2
2
2
2
3
1
1
1
2
0
0
0
0
Expenses
22
11
11
12
24
11
13
13
23
10
9
15
40
32
42
43
44
39
31
55
67
77
73
50
2
2
2
2
3
2
1
1
2
1
1
3
3
0
EBITDA
1
2
2
1
1
2
2
1
1
2
1
1
1
1
1
1
3
1
-1
-0
5
2
4
2
0
0
0
0
-0
0
-0
1
-0
0
-1
-3
-3
-0
Operating Profit %
-30 %
-50 %
-56 %
-41 %
-37 %
13 %
-55 %
-19 %
-16 %
12 %
13 %
8 %
3 %
4 %
3 %
3 %
6 %
4 %
-2 %
-1 %
7 %
2 %
5 %
4 %
12 %
18 %
13 %
1 %
-13 %
8 %
-28 %
53 %
-5 %
11 %
-346 %
-1,857 %
-2,300 %
-48 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
1
1
1
0
0
0
-0
0
0
0
0
0
0
0
0
0
0
Interest
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-0
1
1
0
-0
0
0
0
-0
0
0
0
-0
0
0
-0
2
0
-2
-2
4
0
2
1
0
0
0
-0
-1
0
-0
0
-0
0
-1
-3
-3
-0
Tax
-0
0
0
-0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0
0
1
0
1
0
0
0
0
-0
-0
0
0
0
-0
0
0
0
1
0
Net Profit
-0
0
1
0
-0
1
0
-0
-0
0
0
0
0
1
-1
-0
2
0
-1
-2
2
0
2
1
1
0
0
-0
-0
-0
0
0
-0
0
-1
-3
-4
-0
EPS in ₹
-0.14
0.29
0.38
0.07
-0.25
0.53
0.16
-0.25
-0.14
0.06
0.10
0.06
0.25
0.43
-0.62
-0.09
1.03
0.15
-0.48
-1.02
1.01
0.10
1.25
0.35
0.99
0.11
0.07
-0.11
-0.56
-0.05
0.10
0.56
-0.25
0.02
-1.38
-3.43
-5.10
-0.13
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
67
65
62
74
105
117
21
21
21
7
Fixed Assets
22
22
21
20
21
22
14
14
14
0
Current Assets
43
31
38
52
82
92
6
6
7
6
Capital Work in Progress
0
0
0
0
1
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
45
44
40
53
83
94
6
6
7
7
Total Liabilities
45
42
38
50
80
93
10
10
10
4
Current Liabilities
37
26
30
42
72
84
8
8
7
2
Non Current Liabilities
8
16
8
8
8
9
2
2
3
2
Total Equity
22
23
23
24
25
24
11
11
11
3
Reserve & Surplus
5
6
6
7
8
7
3
3
3
-5
Share Capital
17
17
17
17
17
17
8
8
8
8
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
-0
-0
1
0
-1
8
2
1
4
Investing Activities
0
-1
-1
-1
-3
-3
0
-0
0
12
Operating Activities
-1
1
2
2
7
3
18
2
-0
-5
Financing Activities
2
0
-1
0
-3
-1
-10
-0
1
-3
Above figures are in Rs. Crores

Share Holding

% Holding
Jan 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
10.40 %
10.40 %
15.68 %
15.68 %
15.68 %
15.68 %
15.68 %
15.68 %
15.68 %
21.51 %
7.36 %
7.37 %
7.36 %
1.23 %
1.23 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
6.25 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
89.60 %
89.60 %
84.32 %
84.32 %
84.32 %
84.32 %
84.32 %
84.32 %
84.32 %
78.49 %
92.64 %
92.63 %
92.64 %
98.77 %
92.52 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,870.55 4,48,231.75 42.51 49,887.17 12.06 9,648 42.62 67.80
Cipla
1,643.20 1,32,231.02 29.75 26,520.66 14.17 4,155 17.77 55.33
Dr Reddys Laboratories
6,691.45 1,10,988.19 19.94 28,905.40 12.36 5,578 -0.90 48.83
Mankind Pharma
2,701.30 1,09,421.92 55.76 10,615.63 19.57 1,942 9.89 70.97
Zydus Life Science
1,063.45 1,05,835.69 25.39 19,831.50 13.82 3,831 30.78 34.48
Lupin
2,221.10 1,01,003.81 44.63 20,141.50 19.94 1,936 77.69 57.19
Aurobindo Pharma
1,526.75 88,051.92 24.55 29,559.25 17.55 3,169 61.17 52.73
Alkem Laboratories
6,226.65 72,286.01 33.62 12,978.42 9.84 1,811 91.18 59.26
Glenmark Pharmaceuticals
1,689.20 47,904.26 - 12,653.09 6.58 -1,831 96.52 54.81
Biocon
371.45 45,052.52 28.87 15,621.20 35.25 1,298 478.78 52.54

Corporate Action

Technical Indicators

RSI(14)
Neutral
55.29
ATR(14)
Less Volatile
1.39
STOCH(9,6)
Neutral
22.38
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
Uptrend And Accelerating
0.42
WillR(14)
Neutral
-73.17
Bearish
3
Neutral
3
Bullish
3
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Candlestick Screeners
Technical Screeners
Price & Volume Screeners
Fundamental Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.